A Review of the Neuroprotective Effects of Cinnamon in Experimental Studies on Parkinson's Disease
![]() |
Heo, Hyemin
(Dept. of Korean Medicine, College of Korean Medicine, Woosuk University)
Han, Juhee (Dept. of Korean Medicine, College of Korean Medicine, Woosuk University) Jeong, Minjeong (Dept. of Pediatrics, College of Korean Medicine, Woosuk University) Kim, Hongjun (Dept. of Prescription, College of Korean Medicine, Woosuk University) Jang, Insoo (Dept. of Internal Medicine, College of Korean Medicine, Woosuk University) |
1 | Doo KH, Lee JH, Cho SY, Jung WS, Moon SK, Park JM, et al. A prospective open-label study of combined treatment for idiopathic Parkinson's disease using acupuncture and bee venom acupuncture as an adjunctive treatment. J Altern Complement Med 2015;21(10):598-603. doi: 10.1089/acm.2015.0078 DOI |
2 | Hartmann A, Mullner J, Meier N, Hesekamp H, van Meerbeeck P, Habert MO, et al. Bee venom for the treatment of Parkinson disease - A randomized controlled clinical trial. PLoS One 2016;11(7):e0158235. doi: 10.1371/journal.pone.0158235 DOI |
3 | Yang SB, KIm YJ, Lee HM, Lee SH, cho SY, Park JM, et al. Effects of korean medicine on postural instability and gait difficulty in patient with Parkinsonism: Retrospective Study. J Korean Med 2017;38(3):96-102. doi: 10.13048/jkm.17028 DOI |
4 | Raha S, Dutta D, Roy A, Pahan K. Reduction of Lewy body pathology by oral cinnamon. J Neuroimmune Pharmacol 2020. doi: 10.1007/s11481-020-09955-2 DOI |
5 | Ramazani E, YazdFazeli M, Emami SA, Mohtashami L, Javadi B, Asili J, et al. Protective effects of Cinnamomum verum, Cinnamomum cassia and cinnamaldehyde against 6-OHDA-induced apoptosis in PC12 cells. Mol Biol Rep 2020;47(4):2437-45. doi: 10.1007/s11033-020-05284-y DOI |
6 | Bae WY, Choi JS, Jeong JW. The neuroprotective effects of cinnamic aldehyde in an MPTP mouse model of Parkinson's disease. Int J Mol Sci 2018;19(2):551. doi: 10.3390/ijms19020551. DOI |
7 | Patel D, Jana A, Roy A, Pahan K. Cinnamon and its metabolite protect the nigrostriatum in a mouse model of Parkinson's disease via astrocytic GDNF. J Neuroimmune Pharmacol 2019;14(3):503-18. doi: 10.1007/s11481-019-09855-0 DOI |
8 | Prorok T, Jana M, Patel D, Pahan K. Cinnamic acid protects the nigrostriatum in a mouse model of Parkinson's disease via Peroxisome Proliferator-Activated Receptorα. Neurochem Res 2019;44(4):751-62. doi: 10.1007/s11064-018-02705-0 DOI |
9 | Maiolo SA, Fan P, Bobrovskaya L. Bioactive constituents from cinnamon, hemp seed and polygonum cuspidatum protect against H2O2 but not rotenone toxicity in a cellular model of Parkinson's disease. J Tradit Complement Med 2018;8(3):420-7. doi: 10.1016/j.jtcme.2017.11.001 DOI |
10 | Zeng H, He G, Huang H, Li Y. Protective effect of total flavonoids of Cinnamomi cortex on PC12 cell injured by 6-Hydroxydopamine. Zhong Yao Cai 2017;40(12):2936-40. doi: 10.13863/j.issn1001-4454.2017.12.043 DOI |
11 | Khasnavis S, Pahan K. Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson's disease. J Neuroimmune Pharmacol 2014;9(4):569-81. doi: 10.1007/s11481-014-9552-2 DOI |
12 | Ranasinghe P, Pigera S, Premakumara GAS, Galappaththy P, Constantine GR, Katulanda P. Medicinal properties of 'true' cinnamon (Cinnamomum zeylanicum): a systematic review. BMC Complement Altern Med 2013;13(1):275 doi: 10.1186/1472-6882-13-275 DOI |
13 | Shaltiel-Karyo R, Davidi D, Frenkel-Pinter M, Ovadia M, Segal D, Gazit E. Differential inhibition of α-synuclein oligomeric and fibrillar assembly in Parkinson's disease model by cinnamon extract. Biochim Biophys Acta 2012;1820(10):1628-35. doi: 10.1016/j.bbagen.2012.04.021 DOI |
14 | Khasnavis S, Pahan K. Sodium benzoate, a metabolite of cinnamon and a food additive, upregulates neuroprotective Parkinson disease protein DJ-1 in astrocytes and neurons. J Neuroimmune Pharmacol 2012;7(2):424-35. doi: 10.1007/s11481-011-9286-3 DOI |
15 | Brahmachari S, Jana A, Pahan K. Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses. J Immunol 2009;183(9):5917-27. doi: 10.4049/jimmunol.0803336 DOI |
16 | de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006;5(6):525-35. doi: 10.1016/S1474-4422(06)70471-9 DOI |
17 | Korean medicine pharmacology Compilation committee. Korean medicine pharmacology. 4th ed. Seoul: Shinilbooks; 2015, p. 150-7. |
18 | Neuberger JM, Schweitzer S, Rolland M, Burghard R. Effect of sodium benzoate in the treatment of atypical nonketotic hyperglycinaemia. J Inherit Metab Dis 2000;23(1):22-6. doi: 10.1023/a:1005642728513 DOI |
19 | Leonard JV, Morris AA. Urea cycle disorders. Semin Neonatol 2002;7(1):27-35. doi: 10.1053/siny.2001.0085 DOI |
20 | What is sodium benzoate? Everything you need to know. Healthline. last modified Jan 21, 2019. Available from: https://www.healthline.com/nutrition/sodium-benzoate [accessed Nov 12, 2020] |
21 | CREB. Wikipedia. Available from: https://en.wikipedia.org/wiki/CREB [accessed Oct 11, 2020] |
22 | Yoon MJ, Lee HH. The physiological function of PPARα. Biochemistry and Molecular Biology News 2004;24(1):22-31. |
23 | Ministry of Food and Drug Safety. Integrated pharmaceutical information system: Cinnamon Bark. Available from: https://nedrug.mfds.go.kr/pbp/CCEKP14/selectEkpPopupList [accessed Oct 11, 2020] |
24 | Choe JG. Research on the coumarin analysis in the cinnamon contained foods for standardization & specification. Korea Food & Drug Administration 2009. |
25 | Cho KH. Korean medicine treatment of Parkinson's disease. Paju: Mulgogisup; 2018, p. 123-6. |
26 | The Korean Movement Disorder Society. Report to expand the policy supporting Parkinson's disease in Korea. Seoul: 2007. |
27 | Health Insurance Review and Assessment Service. Disease subclass statistics. Number of patients by year: Parkinson's disease. Available from: http://opendata.hira.or.kr/op/opc/olap3thDsInfo.do [accessed Oct 10, 2020] |
28 | Kim JH. Analysis of prescription of Parkinson's drug using HIRA-NPS data. Master s' thesis, Graduate School of Sungkyunkwan University 2020. |
29 | Lee JJ. Pharmacological treatment in Parkinson's disease. J Korean Neurol Assoc 2019;37(4):335-44. doi: 10.17340/jkna.2019.4.1 DOI |
30 | Guideline center for Korean Medicine. Korean medicine clinical practice guideline for Parkinson's disease. Seoul: 2017. Available from: http://www.nckm.or.kr [accessed Oct 10, 2020] |
31 | Lee SH, Lim S. Clinical effectiveness of acupuncture on Parkinson disease: A PRISMA-compliant systematic review and meta-analysis. Medicine 2017;96(3):e5836. doi: 10.1097/MD.0000000000005836 DOI |
![]() |